Ketamine Hydrochloride 65219-0186-23
- Manufacturer
- Fresenius Kabi Usa, Llc
- Dosage Form
- Injection
- Route
- Intramuscular And Intravenous
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CIII
- Marketing Start
- July 10, 2023
- Listing Expires
- December 31, 2026
- Application
- ANDA215808
Active Ingredients
| Ingredient | Strength |
|---|---|
| Ketamine Hydrochloride | 100 mg/mL |
Drug Class
General Anesthesia [PE]General Anesthetic [EPC]
Selected Package
65219-0186-23Selected10 VIAL in 1 TRAY (65219-186-23) / 5 mL in 1 VIAL (65219-186-13)